Could a single pill ease rigid routines in autism? new study launches

NCT ID NCT05999240

First seen Nov 05, 2025 · Last updated May 12, 2026 · Updated 30 times

Summary

This study tests a drug called pimavanserin to see if it can reduce rigid, repetitive behaviors in people with autism. About 30 people aged 12 to 40 will first receive either the drug or a placebo in a random order, then all can receive the drug openly. The goal is to check safety and whether the drug helps with behavioral inflexibility.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Center for Autism and the Developing Brain

    RECRUITING

    White Plains, New York, 10605, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Kansas, Center for Research

    RECRUITING

    Lawrence, Kansas, 66045, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.